![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif)
erythromycin A broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif)
US brand names: | ![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif) | E-Mycin ERYC Ery-Tab Ilotycin Robimycin RP-Mycin | | ![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081010092524im_/http://cancernet.nci.nih.gov/images/spacer.gif) |